English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Dow expands relationship with DEPI and AVSqrcode

Aug. 12, 2014

Favorites Print
Forward
Aug. 12, 2014

Dow expands relationship with DEPI and AVS

Dow AgroSciences announced that the company has worked with DEPI (Department of Environment and Primary Industries of the State of Victoria) of Australia through its commercial arm - Agriculture Victoria Services Pty Ltd. (AVS) - to apply the company’s EXZACT™ Precision Technology Platform to improve the performance of canola varieties and is adding a new project. Collaborated since 2009, the organizations are now planning to enter into a seventh project together.
 
The project builds on previous work from the collaboration, and is using the EXZACT™ Precision Genome Editing Technology Platform to continue developing new varieties of canola with enhanced performance designed to benefit farmers in Australia and around the world. This new research project will be based at DEPI’s AgriBio research facilities in Bundoora.
 
In addition, AVS has entered into a major Research License Agreement with Dow AgroSciences to conduct research using the company’s proprietary EXZACT Precision Genome Editing Technology Platform to enhance the genetics of crops of importance to Australian primary producers.
 
"Collaboration is essential to advance agriculture, and our continued efforts with the Department of Environment and Primary Industries illustrate the power of our organizations working together to turn ideas into reality for farmers," said Tim Hassinger, President and CEO, Dow AgroSciences. "In fact, we have advanced the EXZACT™ Precision Technology Platform from capability building to a platform technology we use to develop new products. We are delighted to continue this outstanding relationship with scientists at DEPI to advance science and provide solutions that will play a role in moving agriculture forward."
 
Both the new project and the license agreement focus on precision genome editing technologies using EXZACT, which Dow AgroSciences has developed under an exclusive license and collaboration agreement in plants with Sangamo BioSciences, Inc. The EXZACT Precision Technology Platform accelerates the creation of new crop varieties and lines. An additional application of the EXZACT platform is the capability to develop novel gene combinations in commercial varieties that will rapidly allow the production of crops with improved performance.
 
"We see great benefit and potential in collaborating with leading research organisations like Dow AgroSciences," said Professor German Spangenberg, DEPI’s Executive Director, Biosciences Research and Director of AgriBio. "DEPI’s crop innovation partnership with Dow AgroSciences has already achieved major science milestones. It exemplifies the strong focus on targeted research and development within DEPI, supporting a profitable growth agenda for Victoria’s food and fibre sector."
 
Financial details of this transaction were not disclosed.
 

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox